Qilu Pharmaceutical Co., Ltd. is committed to the research and development of drugs for the treatment of common diseases, frequently-occurring diseases and other diseases seriously harmful to human health, with the purpose of safeguarding human health and meeting social needs as its own duty.
Headquartered in Jinan City, Shandong Province, the company is a large-scale comprehensive modern pharmaceutical enterprise in China, specializing in the development, production and sales of preparations and raw materials for the treatment of cancer, cardiovascular and cerebrovascular diseases, anti-infection, mental system, nervous system and ophthalmic diseases.
Company always adhere to the innovation and development strategy, in order to market demand as the core, to product innovation as the forerunner, widely develop scientific research and development at home and abroad to cooperate, pay attention to talent introduction and training, with a high-quality scientific research team, with professional and efficient research and development capabilities, have been successfully developed for nearly a state-level new drugs, for the future development of the company set up a reasonable product line in inquiry, A number of studies have been awarded national and provincial science and technology progress awards, and created good social benefits.
The company has ten production bases of preparation, chemical synthesis, biotechnology, antibiotic fermentation and other modern production workshops. Automatic production lines and other major production equipment and testing instruments are purchased from major professional pharmaceutical equipment manufacturers in the world. Antibiotic API, cephalosporin API, anti-tumor API and other products have been domestic and even the world's leading production capacity and production level.
The company has established a strict and standardized quality control organization and a perfect quality assurance system, and is one of the first batch of GMP certified enterprises by the State Food and Drug Administration. Among them, non-sterile API (fermentation, chemical synthesis), sterile API and a variety of preparations have passed the certification of pharmaceutical regulatory agencies in the United States, the European Union, Australia, the United Kingdom, South Africa and other countries and regions.
With a scientific and complete product structure, the company has marketed more than 270 kinds of products, featuring a wide range of therapeutic fields and product serialization. With excellent product quality and the purpose of serving customers wholeheartedly, Qilu has established its brand in the field of medicine, with world-class sales network all over the country, exported to North America, European Union, Japan, Australia and other places, and presented a completely reliable sincerity to China and the world with excellent service.
The company has developed a unique Qilu enterprise culture and actively advocates the Qilu spirit of "only a state-owned factory can have our happy home", which has realized the common growth of employees and the company. At the same time of rapid development, it earnestly fulfills all social responsibilities, helps the crisis and saves the poor, dedicates love, and shows the development and takeoff of Chinese national pharmaceutical enterprises with brilliant achievements and proud verve.
